Julian Moran, BSc
Rationale and design of the PIONEER PLUS study evaluating high dose oral GLP-1 receptor agonist therapy for the treatment of type 2 diabetes
Rationale and design of the PIONEER PLUS study evaluating high dose oral GLP-1 receptor agonist therapy for the treatment of type 2 diabetes
Advancing Precision Health through the All of Us Research Program: Insights from the New England Consortium
Adaptive adversarial neural networks for the analysis of lossy and domain-shifted datasets of medical images
Computerized clinical decision support: Defining end-user requirements for primary care staff and patients
